Long-term effects of the Focus on Families project on substance use disorders among children of parents in methadone treatment

As recovery from substance use disorder becomes more than a mere quantifiable outcome, there exists a need to discuss and propose the underlying theoretical constructs that ultimately describe and identify the science of recovery. In this abstract undertaking, we propose an initial formulation of a grand theory of recovery science, built upon the seminal theories of recovery capital, recovery-oriented systems of care, and socioecological theory. This grand theory - labeled recovery-informed theory (RIT) - states that successful long-term recovery is self-evident and is a fundamentally emancipatory set of processes. This paper will discuss, analyze, and explore this theory as it is situated within the larger substance use, misuse, and disorder contexts. The uses, implications, and benefits of RIT as an organizing point of inquiry for recovery science are also discussed. By promoting the role of subjective recovery experience in the formulation of the study of recovery, it may be possible to summon new ideas, metrics, and strategies that can directly address substance use disorders in society. Adopting a recovery-informed understanding as follows from this grand theory may allow individual recovery and wellness trajectories to be explored, adapted, and modified to exemplify person-centered and individualized recovery strategies.

Download Full-text

Psychosocial Therapies for Substance Use Disorders

Managing Substance Use Disorder ◽

10.1093/med-psych/9780190926717.003.0005 ◽

2019 ◽

pp. 41-52

Author(s):

Dennis C. Daley ◽

Antoine Douaihy

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

Psychosocial Interventions ◽

Alcohol Problems ◽

Support Programs ◽

Treatment Programs ◽

Mutual Support ◽

Professional Treatment ◽

Drug Problems

There are many counseling approaches, treatment programs, and psychosocial interventions for individuals with substance use disorders (SUDs). Although some have been shown in clinical trials to be more effective than others, to date there is no single, superior treatment approach appropriate for all clients. While brief treatments have been successful with alcohol problems, longer term treatments are often needed for drug problems. For clients with more severe SUDs, long-term involvement in professional treatment (including medication-assisted therapies), mutual support programs, or both may be needed. This chapter includes a summary of treatment principles and guidelines that can serve as a framework for helping clients with SUDs.

Download Full-text

Familial, Social, and Individual Factors Contributing to Risk for Adolescent Substance Use

Journal of Addiction ◽

10.1155/2013/579310 ◽

2013 ◽

Vol 2013 ◽

pp. 1-9 ◽

Cited By ~ 41

Author(s):

Mackenzie Whitesell ◽

Annette Bachand ◽

Jennifer Peel ◽

Mark Brown

Keyword(s):

Substance Use ◽

The United States ◽

Adolescent Substance Use ◽

Physical And Mental Health ◽

Long Term Effects ◽

Adolescent Substance ◽

Sexually Transmitted ◽

Increased Risk ◽

Control And Prevention

Data from the National Institute on Drug Abuse (NIDA) and the Centers for Disease Control and Prevention (CDC) reveal high numbers of adolescent substance use in the United States. Substance use among adolescents can lead to increased risk of transmission of sexually transmitted infections, vehicular fatalities, juvenile delinquency, and other problems associated with physical and mental health. Adolescents are particularly susceptible to involvement in substance use due to the underdeveloped state of the adolescent brain, which can lead to reduced decision-making ability and increased long-term effects of drugs and alcohol. Understanding the causes of adolescent substance use is vital for successful prevention and intervention programs.

Download Full-text

The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality

Drug and Alcohol Dependence ◽

10.1016/j.drugalcdep.2016.08.196 ◽

2017 ◽

Vol 171 ◽

pp. e68

Author(s):

J.R. Gaither ◽

J. Goulet ◽

William Becker ◽

Stephen Crystal ◽

E. Jennifer Edelman ◽

...

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

Opioid Therapy ◽

All Cause Mortality

Download Full-text

Pharmacotherapy for substance use disorders within correctional facilities

10.1093/med/9780199360574.003.0046 ◽

2015 ◽

Author(s):

Sarah E. Wakeman ◽

Josiah D. Rich

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

Behavioral Interventions ◽

Opioid Dependence ◽

Addiction Treatment ◽

Term Treatment ◽

Opiate Dependence ◽

Opioid Use ◽

Long Term Treatment

Drug addiction treatment is increasingly complex. Only 5% of prisons and 34% of jails offer any detoxification services, and only 1% of jails offer methadone for opioid withdrawal. Even fewer facilities offer medication assisted therapy (MAT) for alcohol or substance use disorders despite the tremendous evidence base supporting the use of medications to treat addiction. Untreated opioid dependence both within corrections and in the community is associated with HIV, Hepatitis C, crime, and death by overdose. Substantial evidence argues that these risks are reduced through long-term treatment with agonist medications such as methadone and buprenorphine. Only a minority of prisoners receive any addiction treatment while incarcerated. Those that do are usually offered behavioral interventions, which when used alone have extremely poor outcomes. Although there are limited studies on the outcomes of drug treatment during incarceration, there are nearly 50 years of evidence documenting the efficacy of methadone given in the community in reducing opioid use, drug-related health complications, overdose, death, criminal activity, and recidivism. Buprenorphine is similarly an effective, safe, and cost-effective long-term treatment for opioid dependence that reduces other opioid use and improves health and quality of life outcomes. There is a growing role for MAT in jails, and to a lesser degree in prisons for the treatment of alcohol and opiate dependence. This chapter presents the current state of evidence based practice in correctional MAT models.

Download Full-text

Older patients with substance use disorders require long-term treatment

PsycEXTRA Dataset ◽

10.1037/e493162004-001 ◽

2002 ◽

Author(s):

Brennan

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

Older Patients ◽

Term Treatment ◽

Long Term Treatment

Download Full-text

Methylphenidate and substance abuse: A review of pharmacology, animal, and clinical studies

Journal of Attention Disorders ◽

10.1177/070674370200601s09 ◽

2002 ◽

Vol 6 (1_suppl) ◽

pp. 65-71 ◽

Cited By ~ 36

Author(s):

M. Huss ◽

U. Lehmkuhl

Keyword(s):

Substance Abuse ◽

Attention Deficit Hyperactivity Disorder ◽

Substance Use ◽

Attention Deficit ◽

Prospective Studies ◽

Lower Risk ◽

Abuse Liability ◽

Long Term Effects ◽

Hyperactivity Disorder

This article reviews pharmacological, animal, and human evidence regarding the abuse liability of methylphenidate (MPH). Findings are not always consistent, but evidence converges to suggest that although intravenous methylphenidate has some abuse potential, there is very little potential for oral MPH abuse. Furthermore, the available data suggests that children with Attention-Deficit/Hyperactivity Disorder (ADHD) who are treated with MPH are at lower risk for substance use disorder later in life. More longitudinal, prospective studies are needed to assess the long term effects of MPH treatment in ADHD.

Download Full-text